tiprankstipranks
Trending News
More News >
Capha Pharmaceuticals Inc. (FPSUF)
OTHER OTC:FPSUF
US Market

Capha Pharmaceuticals (FPSUF) Income Statement

Compare
1 Followers

Capha Pharmaceuticals Income Statement

Last quarter (Q2 2025), Capha Pharmaceuticals's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Capha Pharmaceuticals's net income was C$-14.73K. See Capha Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00----
Operating Expenses
C$ 50.74KC$ 53.00KC$ 57.68KC$ 44.49KC$ 50.23K
Depreciation and Amortization
C$ 133.00----
EBITDA
C$ -50.74KC$ -53.22K-C$ -44.49K-
Operating Income
C$ -50.74KC$ -53.14KC$ -57.89KC$ -44.80KC$ -50.71K
Other Income/Expenses
C$ -20.03KC$ -222.00C$ -414.00C$ -5.00C$ -450.00
Pretax Income
C$ -70.77KC$ -53.36KC$ -58.31KC$ -44.81KC$ -51.16K
Net Income
C$ -70.77KC$ -53.36KC$ -58.31KC$ -44.81KC$ -51.16K
Per Share Metrics
Basic EPS
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Diluted EPS
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Weighted Average Shares Outstanding
64.46M 64.48M 64.43M 64.43M 64.43M
Weighted Average Shares Outstanding (Diluted)
64.43M 64.43M 64.43M 64.43M 64.43M
Currency in CAD

Capha Pharmaceuticals Earnings and Revenue History